Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MIRACLE: Lopinavir/Ritonavir + Interferon Beta-1b for MERS
NCT02845843Phase 3Completed
- Sponsor
- King Abdullah International Medical Research Center
- Start
- Jul 2016
- Primary completion
- May 2020
- Modality
- Cytokines & Interferons, Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of lopinavir + ritonavir, interferon beta-1b in Middle East respiratory syndrome (MERS), sponsored by King Abdullah International Medical Research Center. Started Jul 2016; status: completed.
02
Drugs
lopinavir + ritonavirinterferon beta-1b
03
Conditions
Middle East respiratory syndrome (MERS)
Beyond the preview
Go deeper on NCT02845843.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02845843.